Gene expression pathways of high grade localized prostate cancer. - Wikidata - wikimedia - TriplyDB

Gene expression pathways of high grade localized prostate cancer.

Gene expression pathways of high grade localized prostate cancer.

http://www.wikidata.org/entity/Q33832517

about

Active surveillance and focal therapy for low-intermediate risk prostate cancer Notch signaling in prostate cancer: refining a therapeutic opportunity Notch signaling in prostate cancer: a moving target Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.Downregulation of EphA5 by promoter methylation in human prostate cancer.Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.Tissue biomarkers for prostate cancer radiation therapy.Sox9 is required for prostate development and prostate cancer initiation Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.Notch Signaling and the Skeleton.Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells.Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection.Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer.DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.Hypoxia, notch signalling, and prostate cancer.Disruption of prostate epithelial differentiation pathways and prostate cancer development.Microarray analysis of copy-number variations and gene expression profiles in prostate cancer.Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer.Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia.HES6 promotes prostate cancer aggressiveness independently of Notch signalling.Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer.Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy.ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models.miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer.MicroRNA expression profiling of Xp11 renal cell carcinoma.Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.

P2860

Q26773641-BD32C478-B32A-49DF-BEBF-FC7B74827428 Q26777624-B2E47D4E-8E39-441D-8429-E1BDAB658FA6 Q27001047-AB2E2873-D423-4818-9AE4-9B301A3ED5B0 Q34084254-F8DDBF85-A7DB-4919-8DF0-54D3C3823B70 Q35017605-FB307738-B4F2-4B9D-943A-1591DEF9096C Q35096116-BB70925E-36FF-441A-B3DE-8BD1240E3E21 Q35678391-4F54687C-D920-49C8-B8C5-F1F4E6F4884F Q35821224-22210B2C-B0EE-493E-A627-F4DAEA03E6E5 Q36141341-EB3908D8-AEFE-4817-AB15-612CBE52CCCA Q36234048-E0BFC942-48E2-4B55-92E0-08E3EADAF507 Q36236135-32661C30-3B8C-4E2D-B915-9920929E7DA2 Q36500392-C636FBF8-16BF-47FE-AED9-15802504C7D1 Q36960089-1BB808EC-FC38-49CB-9340-F2C794B3BBC1 Q37097040-757A3F01-DEE8-40B9-9E6F-CF661D78EF78 Q37182674-A224CFF1-06D0-4A8C-B987-35D43569C8A4 Q37210051-DD51831A-69F3-4522-8E09-F60A619E1A28 Q37308114-E22AE1CC-8EAF-4B35-B2C9-C05B6B4C1C3E Q37445211-D281BCA4-D7C5-43E2-A5D7-839F713B0FAD Q37508608-7D483D06-7642-4D64-A37F-42E5315496BF Q37565364-FFFF5E98-67CD-4E47-AB04-3E4ADBDD406C Q37589392-A0E5350E-EBA4-4CA5-B296-0FC649A66AA7 Q38160495-97448195-D644-49AD-A4DD-5C50376F2605 Q38682456-5420B9A9-3764-4B3F-8DF3-FD6CE5E9D656 Q38849027-C8C56C78-E8CD-42C9-B4A4-7FFC4E46981D Q38850154-6C0120B3-6B1D-49E4-89F7-C7ED608D3F40 Q38865256-D9805526-B3A2-4CDF-AC8A-CCED11E787CD Q38888488-99089C2D-CC15-4209-8F61-756E04AC077C Q39211272-F03E66A0-BE46-4089-956A-D6EE6425E4BA Q40068242-8D3AB15B-6BE0-418B-8EEF-087828FAB322 Q47107021-6568E2D7-BD6A-40F4-A3F8-1070479A55B3 Q47142179-70428E2E-4C2D-4AAD-BB3C-895FCA22D356 Q48176559-4668CAC3-F66F-4C1B-AF8A-86787ADF34C5 Q50726690-37BB2140-BD16-4580-866B-CB97BEEF6AAF Q52645860-16C05384-7CDC-46D9-BD83-98937CAEA42D Q55286883-DA564C43-0E62-466B-A398-5BD2E283673D

P2860

Gene expression pathways of high grade localized prostate cancer.

http://www.wikidata.org/entity/Q33832517

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Gene expression pathways of high grade localized prostate cancer.

@ast

Gene expression pathways of high grade localized prostate cancer.

@en

type

label

Gene expression pathways of high grade localized prostate cancer.

@ast

Gene expression pathways of high grade localized prostate cancer.

@en

prefLabel

Gene expression pathways of high grade localized prostate cancer.

@ast

Gene expression pathways of high grade localized prostate cancer.

@en

P1433

Q33832517-80B3AA8C-1BF5-40DD-89ED-ED722771B2E3

P1476

Q33832517-18406128-D7D7-4698-91AF-78A11462CCB1

P2093

Q33832517-01B85297-24A5-4615-9EB2-2EE9D5E86F2C

Q33832517-3C53669B-502D-440A-8D53-D9BBFEA3D766

Q33832517-8F8026D1-0DC4-4C1F-A053-BB658AAC2FB4

Q33832517-B82B3268-B07C-4E84-9E9F-F48A19FA641B

P2860

Q33832517-042E406C-C8C6-430E-994D-9F25CDA7E6AA

Q33832517-054A8D9E-7BE2-4AF6-8F53-F0533D858D47

Q33832517-1135C96F-AB17-4CE2-BA52-6288EFF732C4

Q33832517-13138B48-918F-449E-A336-93A3352CFEC3

Q33832517-147232C7-857D-4966-930A-47AD18D0334F

Q33832517-171E7E1E-2BB0-44EA-9CD4-4439659441FF

Q33832517-279F5DC5-8839-40FE-8CC3-B71881F5A1AD

Q33832517-296C359D-D7BF-4CD4-A84B-71129DAFA16F

Q33832517-2E660C36-DEF0-4852-AD7C-DFBD3D86E4CB

Q33832517-3DA2DD42-F7C5-4CC1-91CF-BEEE69C99FB2

P304

Q33832517-803EB10B-2A35-493F-9CD9-477BB37C9B9F

P31

Q33832517-B942C068-78A9-41B0-B95D-858B039204BB

P356

Q33832517-C0AF8B0D-AD3B-4EE6-87DC-E4F10DF398B3

P433

Q33832517-91E7BB67-0D65-4450-945A-E7D87A91FD19

P478

Q33832517-F2E885AB-554F-4C37-9C0B-2CF2FEAB9541

P50

Q33832517-02CC7A11-F3C0-4093-8C59-53F1DC60C652

Q33832517-512C8FDD-7196-4705-AE24-9EEA0E94DCB8

Q33832517-B3AD7AD7-E384-490A-A15A-CE772C0CCD52

P577

Q33832517-06DDAD43-FBFC-4259-B447-A6E9EDEB73E5

P698

Q33832517-2C58BE01-37F3-45A4-B851-55B84080FE13

P356

P1433

P1476

Gene expression pathways of high grade localized prostate cancer.

@en

P2093

Chris Cheadle

http://www.w3.org/2001/XMLSchema#string

Jinshui Fan

http://www.w3.org/2001/XMLSchema#string

Luigi Marchionni

http://www.w3.org/2001/XMLSchema#string

Milena Vuica-Ross

http://www.w3.org/2001/XMLSchema#string

P2860

The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells

4E-BP1 is a target of Smad4 essential for TGFbeta-mediated inhibition of cell proliferation

A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase

Cancer statistics, 2010

Cancer-related inflammation

PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth

The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer

Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer

Stress-activated cap'n'collar transcription factors in aging and human disease

P304

1568-1577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.21373

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Edward M Schaeffer

P577

2011-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21360566

http://www.w3.org/2001/XMLSchema#string